A role for cyclooxygenase in aging-related changes of β-adrenoceptor-mediated relaxation in rat aortas

  • Khong Bee Kang
  • M. A. Sharmini Rajanayagam
  • Andrea van der Zypp
  • Henryk Majewski
Original Article


β-Adrenoceptor-mediated vasorelaxation decreases with age in various vascular beds. The present study investigated the roles of cyclooxygenase (COX) on β-adrenoceptor vasorelaxation by isoprenaline in 8- and 54-week-old rat aortas. The vasorelaxation responses by isoprenaline (0.03–3 μM) were significantly reduced in 54-week-old aortas compared to 8-week. Addition of the non-selective COX inhibitors indomethacin (10 μM) or aspirin (10 μM) restored isoprenaline vasorelaxation of 54-week-old aortas to levels found in 8-week-old aortas. This suggests the involvement of COX prostanoids in the age-related reduction of β-adrenoceptor vasorelaxation. Immunohistochemistry revealed greater levels of COX-1 and COX-2 staining in 54-week-old aortas compared to 8-week with expression located mainly in medial smooth muscle. An age-linked increase in COX-1 and COX-2 protein was found in cremaster arterioles of 54-week-old rats (compared to 8-week) mainly in the endothelial layer. The age-related increase in COX-1 and COX-2 protein led to elevation of prostacyclin (measured as 6-keto prostaglandin \( {\text{F}}_{{1\alpha }} \)) and thromboxane A2 (measured as thromboxane B2) in 54-week compared to 8-week-old aortas. Endothelium removal in 54-week aortas markedly reduced the 6-keto prostaglandin \( {\text{F}}_{{1\alpha }} \) level, thus suggesting an endothelial source for elevated prostacyclin. These findings in combination with the effects of COX inhibitors suggest that the age-related decrease in β-adrenoceptor vasorelaxation by isoprenaline is due to an age-linked increase in COX expression, which elevates production of COX-derived vasoactive prostanoids.


β-adrenoceptor Age Endothelium Cyclooxygenase Prostacyclin Aorta 











physiological salt solution


  1. Arribas S, Marin J, Ponte A, Balfagon G, Salaices M (1994) Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension. J Pharmacol Exp Ther 270:520–527PubMedGoogle Scholar
  2. Arribas SM, Vila E, McGrath JC (1997) Impairment of vasodilator function in basilar arteries from aged rats. Stroke 28:1812–1820PubMedGoogle Scholar
  3. Bieger D, Parai K, Ford CA, Tabrizchi R (2006) Beta-adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels. Naunyn-Schmiedebergs Arch Pharmacol 373:186–196PubMedCrossRefGoogle Scholar
  4. Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA (1997) Characterization of the induction of nitric oxide synthase and cyclo- oxygenase in rat aorta in organ culture. Br J Pharmacol 121:125–133PubMedCrossRefGoogle Scholar
  5. Bishop-Bailey D, Hla T, Mitchell JA (1999) Cyclo-oxygenase-2 in vascular smooth muscle. Int J Mol Med 3:41–48PubMedGoogle Scholar
  6. Borkowski KR, Gros R, Schneider H (1992) Vascular beta-adrenoceptor-mediated responses in hypertension and ageing in rats. J Auton Pharmacol 12:389–401PubMedGoogle Scholar
  7. Briones AM, Montoya N, Giraldo J, Vila E (2005a) Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton Autacoid Pharmacol 25:155–162PubMedCrossRefGoogle Scholar
  8. Briones AM, Salaices M, Vila E (2005b) Ageing alters the production of nitric oxide and prostanoids after IL-1beta exposure in mesenteric resistance arteries. Mech Ageing Dev 126:710–721PubMedCrossRefGoogle Scholar
  9. Chang WC, Murota SI, Nakao J, Orimo H (1980) Age-related decrease in prostacyclin biosynthetic activity in rat aortic smooth muscle cells. Biochim Biophys Acta 620:159–166PubMedGoogle Scholar
  10. Clapp LH, Turcato S, Hall S, Baloch M (1998) Evidence that Ca2+-activated K+ channels play a major role in mediating the vascular effects of iloprost and cicaprost. Eur J Pharmacol 356:215–224PubMedCrossRefGoogle Scholar
  11. De Mey JG, Vanhoutte PM (1982) Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res 51:439–447PubMedGoogle Scholar
  12. Deisher TA, Mankani S, Hoffman BB (1989) Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age. J Pharmacol Exp Ther 249:812–819PubMedGoogle Scholar
  13. Delpy E, Coste H, Gouville AC (1996) Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br J Pharmacol 119:471–478PubMedGoogle Scholar
  14. Dorn GW 2nd, Becker MW, Davis MG (1992) Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 267:24897–24905PubMedGoogle Scholar
  15. El-Mas MM, Mohy El-Din MM, El-Gowilly SM, Sharabi FM (2004) Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations. Eur J Pharmacol 487:149–158PubMedCrossRefGoogle Scholar
  16. Feletou M, Moreau N, Boulanger M, Duhault J (1993) Effect of aging and drug-induced weight reduction on rat vascular reactivity. J Cardiovasc Pharmacol 21:120–127PubMedCrossRefGoogle Scholar
  17. Ford GA, Hoffman BB, Vestal RE, Blaschke TF (1992) Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol 33:83–87PubMedGoogle Scholar
  18. Frazier EP, Schneider T, Michel MC (2006) Effects of gender, age and hypertension on beta-adrenergic receptor function in rat urinary bladder. Naunyn-Schmiedebergs Arch Pharmacol 373:300–309PubMedCrossRefGoogle Scholar
  19. Gardiner SM, Kemp PA, Bennett T (1991) Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5′-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol 103:1725–1732PubMedGoogle Scholar
  20. Giani E, Masi I, Galli C (1985) Platelets from aged rats aggregate more, but are more sensitive to prostacyclin. Prostaglandins Leukot Med 20:237–246PubMedCrossRefGoogle Scholar
  21. Graves J, Poston L (1993) Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 108:631–637PubMedGoogle Scholar
  22. Gray DW, Marshall I (1992) Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 107:684–690PubMedGoogle Scholar
  23. Gurdal H, Friedman E, Johnson MD (1995) Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta. Mol Pharmacol 47:772–778PubMedGoogle Scholar
  24. Heymes C, Habib A, Yang D, Mathieu E, Marotte F, Samuel J, Boulanger CM (2000) Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol 131:804–810PubMedCrossRefGoogle Scholar
  25. Hull MA (2005) Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur J Cancer 41:1854–1863PubMedCrossRefGoogle Scholar
  26. Hyland L, Warnock P, Docherty JR (1987) Age-related alterations in alpha 1- and beta-adrenoceptors mediated responsiveness of rat aorta. Naunyn-Schmiedebergs Arch Pharmacol 335:50–53PubMedCrossRefGoogle Scholar
  27. Ikezono K, Zerkowski HR, Beckeringh JJ, Michel MC, Brodde OE (1987) Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein. J Pharmacol Exp Ther 241:294–299PubMedGoogle Scholar
  28. Johnson MD, Zhou Y, Friedman E, Roberts J (1995) Expression of G protein alpha subunits in the aging cardiovascular system. J Gerontol A Biol Sci Med Sci 50A:B14–B19PubMedGoogle Scholar
  29. Kamata K, Miyata N, Kasuya Y (1989) Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 249:890–894PubMedGoogle Scholar
  30. Konishi M, Su C (1983) Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5:881–886PubMedGoogle Scholar
  31. Lu Z, Qu P, Xu K, Han C (1995) Beta-adrenoceptors in endothelium of rabbit coronary artery and alteration in atherosclerosis. Biol Signals 4:150–159PubMedGoogle Scholar
  32. Marin J, Rodriguez-Martinez MA (1999) Age related changes in vascular responses. Exp Gerontol 34:503–512PubMedCrossRefGoogle Scholar
  33. Matz RL, de Sotomayor MA, Schott C, Stoclet JC, Andriantsitohaina R (2000a) Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 131:303–311PubMedCrossRefGoogle Scholar
  34. Matz RL, Schott C, Stoclet JC, Andriantsitohaina R (2000b) Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 49:11–18PubMedGoogle Scholar
  35. Matz RL, Van Overloop B, Gaubert E, Gairard A (2001) Maturation reveals a decrease in endothelium-dependent contraction induced by depolarization in the aorta of spontaneously hypertensive rats. Life Sci 69:1791–1804PubMedCrossRefGoogle Scholar
  36. Menconi M, Taylor L, Martin B, Polgar P (1987) A review: prostaglandins, aging, and blood vessels. J Am Geriatr Soc 35:239–247PubMedGoogle Scholar
  37. Moncada S, Rees DD, Schulz R, Palmer RM (1991) Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88:2166–2170PubMedCrossRefGoogle Scholar
  38. Numaguchi Y, Harada M, Osanai H, Hayashi K, Toki Y, Okumura K, Ito T, Hayakawa T (1999) Altered gene expression of prostacyclin synthase and prostacyclin receptor in the thoracic aorta of spontaneously hypertensive rats. Cardiovasc Res 41:682–688PubMedCrossRefGoogle Scholar
  39. O’Donnell SR, Wanstall JC (1986) Thyroxine treatment of aged or young rats demonstrates that vascular responses mediated by beta-adrenoceptor subtypes can be differentially regulated. Br J Pharmacol 88:41–49PubMedGoogle Scholar
  40. Osanai T, Matsumura H, Kikuchi T, Minami O, Yokono Y, Akiba R, Eidou H, Konta A, Kanazawa T, Onodera K et al (1990) Changes in vascular wall production of prostacyclin and thromboxane A2 in spontaneously hypertensive rats during maturation and the concomitant development of hypertension. Jpn Circ J 54:507–514PubMedGoogle Scholar
  41. Pan HY, Hoffman BB, Pershe RA, Blaschke TF (1986) Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther 239:802–807PubMedGoogle Scholar
  42. Panganamala RV, Hanumaiah B, Merola AJ (1981) Age-related increase in prostacyclin production in the rat aorta. Prostaglandins Med 6:233–235PubMedCrossRefGoogle Scholar
  43. Pourageaud F, Leblais V, Bellance N, Marthan R, Muller B (2005) Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery. Naunyn-Schmiedebergs Arch Pharmacol 372:14–23PubMedCrossRefGoogle Scholar
  44. Rubanyi G, Vanhoutte PM (1985) Endothelium-removal decreases relaxations of canine coronary arteries caused by beta-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 7:139–144PubMedCrossRefGoogle Scholar
  45. Sawyer R, Docherty JR (1987) Reduction with age in the relaxation to beta-adrenoceptor agonists and other vasodilators in rat aorta. Naunyn-Schmiedebergs Arch Pharmacol 336:60–63PubMedGoogle Scholar
  46. Shimizu I, Toda N (1986) Alterations with age of the response to vasodilator agents in isolated mesenteric arteries of the beagle. Br J Pharmacol 89:769–778PubMedGoogle Scholar
  47. Stewart KG, Zhang Y, Davidge ST (2000) Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries. Hypertension 35:1242–1247PubMedGoogle Scholar
  48. Tilley SL, Coffman TM, Koller BH (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108:15–23PubMedCrossRefGoogle Scholar
  49. Todd MK, Goldfarb AH, Kauffman RD, Burleson C (1994) Combined effects of age and exercise on thromboxane B2 and platelet activation. J Appl Physiol 76:1548–1552PubMedGoogle Scholar
  50. Tsujimoto G, Lee CH, Hoffman BB (1986) Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther 239:411–415PubMedGoogle Scholar
  51. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M (2005) Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 338:70–76PubMedCrossRefGoogle Scholar
  52. van der Zypp A, Kang KB, Majewski H (2000) Age-related involvement of the endothelium in beta-adrenoceptor- mediated relaxation of rat aorta. Eur J Pharmacol 397:129–138PubMedCrossRefGoogle Scholar
  53. Yamaki F, Kaga M, Horinouchi T, Tanaka H, Koike K, Shigenobu K, Toro L, Tanaka Y (2001) MaxiK channel-mediated relaxation of guinea-pig aorta following stimulation of IP receptor with beraprost via cyclic AMP-dependent and -independent mechanisms. Naunyn Schmiedebergs Arch Pharmacol 364:538–550PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Khong Bee Kang
    • 1
  • M. A. Sharmini Rajanayagam
    • 1
  • Andrea van der Zypp
    • 1
  • Henryk Majewski
    • 1
  1. 1.School of Medical SciencesRMIT UniversityBundooraAustralia

Personalised recommendations